|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1993-9-29
|
|
pubmed:abstractText |
The importance of CD4+ cells and gamma interferon (IFN-gamma) in the resolution of established Cryptosporidium parvum infection was investigated with a murine model of cryptosporidiosis in severe combined immunodeficient (SCID) mice. C. parvum-infected SCID mice were reconstituted with spleen cells from immunocompetent donors. The recipients were able to resolve their C. parvum infection by 17 days postreconstitution. Treatment of reconstituted SCID mice with either anti-CD4 monoclonal antibodies to deplete them of CD4+ cells or with anti-IFN-gamma to neutralize IFN-gamma activity reduced or eliminated their ability to resolve C. parvum infection whereas treatment with either anti-CD8 monoclonal antibodies or anti-asialo-GM1 antibodies had no effect. We also found C. parvum-specific antibodies in serum samples from two of four reconstituted SCID mice killed on postreconstitution day 17 but not in unreconstituted SCID mice. Moreover, anti-CD4-treated mice had no detectable specific antibodies to C. parvum, whereas all mice treated with either anti-CD8 or anti-asialo-GM1 had substantial levels of specific antibodies in their serum. Although the role of the specific antibody is not known, these findings clearly indicate that resolution of an established C. parvum infection in immunologically reconstituted SCID mice is dependent on both CD4+ cells and IFN-gamma.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-1348918,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-1355103,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-1500156,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-15463522,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-1548057,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-1649870,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-1677668,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-1683358,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-1804781,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-1818124,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-1818204,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-1955748,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-2037795,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-2117637,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-2610438,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-2996403,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-3100664,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-3275728,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8103040-8335387
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0019-9567
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
61
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3928-32
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Requirements for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice.
|
|
pubmed:affiliation |
Trudeau Institute, Inc., Saranac Lake, New York 12983.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
